Compare BBDC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBDC | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 912.0M | 910.2M |
| IPO Year | 2006 | 2016 |
| Metric | BBDC | BVS |
|---|---|---|
| Price | $8.61 | $10.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $9.71 | ★ $16.60 |
| AVG Volume (30 Days) | 520.8K | ★ 606.9K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | ★ 12.09% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | ★ 0.78 | 0.60 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $4.72 |
| Revenue Next Year | $2.11 | $6.41 |
| P/E Ratio | ★ $11.03 | $18.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.97 | $6.47 |
| 52 Week High | $9.54 | $15.89 |
| Indicator | BBDC | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 33.79 |
| Support Level | $8.40 | $8.21 |
| Resistance Level | $8.71 | $11.00 |
| Average True Range (ATR) | 0.19 | 0.66 |
| MACD | 0.01 | -0.24 |
| Stochastic Oscillator | 38.81 | 15.20 |
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. It employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.